In this Issue
GUEST CHIEF MEDICAL EDITORS’ PAGE
By Daniel G. Clair, MD; and Timothy A. Resch, MD, PhD
Anatomic risk factors associated with an increased risk of proximal seal failure with standard EVAR in the era of device and technique advancement.
By Graeme McFarland, MD; and Jason T. Lee, MD
How to overcome juxtarenal AAAs.
By Cornelis G. Vos, MD, PhD; Richte C.L. Schuurmann, MSc; and Jean-Paul P.M. de Vries, MD, PhD
An overview of today’s available devices to overcome a hostile neck.
By Salma El Batti, MD, PhD; Anna Prent, MD, FEBVS; and Tara M. Mastracci, MD, MSc, FRCSC, FACS, FRCS
With Naiem Nassiri, MD, RPVI; Alan Dardik, MD, PhD; Hence J.M. Verhagen, MD, PhD; Stéphan Haulon, MD, PhD; Claire Watkins, MD; Dominique Fabre, MD; and Gustavo S. Oderich, MD
A review of the various indications for reintervening after infrarenal EVAR and the technical options available.
By Nuno V. Dias, MD, PhD; Björn Sonesson, MD, PhD; and Tim Resch, MD, PhD
A discussion of patient selection and when open repair should be considered based on the type of endoleak and presence of infection.
By Zachary M. Arthurs, MD
Prof. Jan Blankensteijn compares the results from the EVAR 1 and DREAM trials and discusses possible shortcomings of these data and the path ahead for future investigation.
With Jan Blankensteijn, MD, PhD
A review of the approach to treatment for primary and secondary aortic infections.
By Anders Wanhainen, MD, PhD; Karl Sörelius, MD, PhD; Hamid Gavali; and Kevin Mani, MD, PhD
FEATURED TECHNOLOGYSponsored by Endologix
With Salem M. George Jr, MD, FACS; Venkatesh Ramaiah, MD, FACS; and Matt Thompson, MD, FRCS
EUROPEAN FEATURED TECHNOLOGYSponsored by Cordis, a Cardinal Health company
By Enrico Maria Marone, MD
SUPERFICIAL VENOUS DISEASE
A rundown of five significant advancements seen in the past year for the treatment and management of superficial venous disease.
By Raghu Kolluri, MD, RVT, RPVI; and Brian Fowler, BS, RVT
Evaluating the data to better predict and prevent varicose vein recurrence.
By Sergio Gianesini, MD, PhD
A panel discusses how they navigate the technologies available for treating superficial venous disease and the factors that influence widespread adoption.
With Julianne Stoughton, MD, FACS; Thomas Proebstle, MD; Neil Khilnani, MD, FSIR, FACPh; and Steve Elias, MD, FACS, FACPh
Dr. Branzan discusses various technical aspects of current approaches to TAAA repair, her belief in multidisciplinary cooperation, and the advancements she hopes to see during her career in vascular medicine.